Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 6:25 PM View:  | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 14-May-24 | Option Exercise | 75,000 | $8.82 | $661,500.00 | 170% 44.09K to 119.09K | |
| Yesterday 6:25 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 14-May-24 | Planned Option Sale | 75,000 | $28.28 | $2,121,040.00 | (63%) 119.09K to 44.09K | |
| 07-May-24 9:52 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 07-May-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 25% 112.12K to 140.12K | |
| 07-May-24 9:52 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 07-May-24 | Planned Option Sale | 28,000 | $25.54 | $715,050.00 | (20%) 140.12K to 112.12K | |
| 22-Apr-24 5:28 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Apr-24 | Option Exercise | 5,000 | $1.24 | $6,200.00 | 2% 268.7K to 273.7K | |
| 22-Apr-24 5:28 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Apr-24 | Planned Option Sale | 5,000 | $22.82 | $114,123.00 | (2%) 273.7K to 268.7K | |
| 03-Apr-24 8:26 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 03-Apr-24 | Private Sale | 20,000 | $27.11 | $542,214.00 | (7%) 288.7K to 268.7K | |
| 03-Apr-24 6:16 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 02-Apr-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 25% 112.12K to 140.12K | |
| 03-Apr-24 6:16 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 02-Apr-24 | Option Sale | 28,000 | $26.25 | $734,919.00 | (20%) 140.12K to 112.12K | |
| 21-Mar-24 4:10 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Mar-24 | Option Exercise | 5,000 | $1.24 | $6,200.00 | 2% 288.7K to 293.7K | |
| 21-Mar-24 4:10 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Mar-24 | Option Sale | 5,000 | $23.97 | $119,848.00 | (2%) 293.7K to 288.7K | |
| 15-Mar-24 4:12 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 13-Mar-24 | Option Exercise | 40,000 | $8.82 | $352,800.00 | 91% 44.09K to 84.09K | |
| 15-Mar-24 4:12 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 13-Mar-24 | Option Sale | 40,000 | $24.52 | $980,760.00 | (48%) 84.09K to 44.09K | |
| 12-Mar-24 8:41 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Sale | 2,641 | $22.03 | $58,189.40 | (< 1%) 291.34K to 288.7K | |
| 12-Mar-24 5:29 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 25% 112.12K to 140.12K | |
| 12-Mar-24 5:29 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Option Sale | 28,000 | $22.63 | $633,682.00 | (20%) 140.12K to 112.12K | |
| 12-Mar-24 8:41 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Option Sale | 25,000 | $22.03 | $550,828.00 | (8%) 316.34K to 291.34K | |
| 12-Mar-24 8:41 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Option Exercise | 25,000 | $1.24 | $31,000.00 | 9% 291.34K to 316.34K | |
| 12-Mar-24 5:29 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 08-Mar-24 | Option Sale | 84,000 | $21.39 | $1,796,710.00 | (43%) 196.12K to 112.12K | |
| 12-Mar-24 5:29 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 08-Mar-24 | Option Exercise | 84,000 | $1.24 | $104,160.00 | 75% 112.12K to 196.12K | |
| 05-Mar-24 4:53 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 01-Mar-24 | Option Exercise | 84,000 | $1.24 | $104,160.00 | 75% 112.12K to 196.12K | |
| 05-Mar-24 4:53 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 01-Mar-24 | Option Sale | 84,000 | $20.13 | $1,691,310.00 | (43%) 196.12K to 112.12K | |
| 23-Jan-24 3:11 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 22-Jan-24 | Sale (Planned) | 1,616 | $10.13 | $16,370.10 | (9%) 18.5K to 16.88K | |
| 23-Jan-24 3:12 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 22-Jan-24 | Sale (Planned) | 4,129 | $10.13 | $41,826.80 | (10%) 40.0K to 35.87K | |
| 23-Jan-24 3:11 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 22-Jan-24 | Sale (Planned) | 2,065 | $10.13 | $20,918.50 | (11%) 19.1K to 17.04K | |
| 23-Jan-24 3:14 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 22-Jan-24 | Sale (Planned) | 1,859 | $10.13 | $18,831.70 | (< 1%) 293.2K to 291.34K | |
| 23-Jan-24 3:13 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 22-Jan-24 | Sale (Planned) | 5,092 | $10.13 | $51,582.00 | (10%) 49.1K to 44.01K | |
| 23-Jan-24 3:11 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 20-Jan-24 | Grant | 16,500 | -- | -- | 1722% 0.96K to 17.46K | |
| 23-Jan-24 3:13 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 20-Jan-24 | Grant | 62,500 | -- | -- | 1327% 4.71K to 67.21K | |
| 23-Jan-24 3:11 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 20-Jan-24 | Grant | 22,500 | -- | -- | 478% 4.71K to 27.21K | |
| 23-Jan-24 3:12 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 20-Jan-24 | Grant | 20,000 | -- | -- | 6897% 0.29K to 20.29K | |
| 14-Dec-23 6:50 AM View: | Wilson Troy Edward Director | Avidity Biosciences, Inc. (RNA) | 12-Dec-23 | Disposition (other) | 550,000 | -- | -- | (42%) 1.32M to 771.25K | |
| 14-Dec-23 6:50 AM View: | Wilson Troy Edward Director | Avidity Biosciences, Inc. (RNA) | 12-Dec-23 | Acquisition (other) | 550,000 | -- | -- | 71% 771.25K to 1.32M | |
| 17-Mar-23 4:36 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 15-Mar-23 | Planned Option Sale | 100 | $22.01 | $2,201.00 | (< 1%) 293.3K to 293.2K | |
| 17-Mar-23 4:36 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 15-Mar-23 | Option Exercise | 100 | $1.24 | $124.00 | < 1% 293.2K to 293.3K | |
| 15-Feb-23 8:30 PM View: | Levin Arthur A Chief Scientific Officer | Avidity Biosciences, Inc. (RNA) | 14-Feb-23 | Planned Option Sale | 10,000 | $23.66 | $236,567.00 | (3%) 303.2K to 293.2K | |
| 15-Feb-23 8:30 PM View: | Levin Arthur A Chief Scientific Officer | Avidity Biosciences, Inc. (RNA) | 14-Feb-23 | Option Exercise | 10,000 | $1.24 | $12,400.00 | 3% 293.2K to 303.2K | |
| 03-Feb-23 5:26 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 03-Feb-23 | Option Exercise | 3,221 | $1.24 | $3,994.04 | 6% 53.35K to 56.57K | |
| 03-Feb-23 5:26 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 03-Feb-23 | Planned Option Sale | 3,221 | $24.26 | $78,141.50 | (6%) 56.57K to 53.35K | |
| 03-Feb-23 5:26 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 02-Feb-23 | Option Exercise | 45,879 | $1.24 | $56,890.00 | 86% 53.35K to 99.23K | |
| 03-Feb-23 5:26 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 02-Feb-23 | Planned Option Sale | 45,879 | $24.36 | $1,117,740.00 | (46%) 99.23K to 53.35K | |
| 03-Feb-23 5:26 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 01-Feb-23 | Option Exercise | 900 | $1.24 | $1,116.00 | 2% 53.35K to 54.25K | |
| 03-Feb-23 5:26 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 01-Feb-23 | Planned Option Sale | 900 | $24.27 | $21,844.40 | (2%) 54.25K to 53.35K | |
| 24-Jan-23 9:13 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 20-Jan-23 | Grant | 50,000 | -- | -- | 1492% 3.35K to 53.35K | |
| 24-Jan-23 9:06 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 20-Jan-23 | Grant | 18,500 | -- | -- | 552% 3.35K to 21.85K | |
| 24-Jan-23 9:10 PM View: | Flanagan W. Michael Chief Technical Officer | Avidity Biosciences, Inc. (RNA) | 20-Jan-23 | Grant | 40,000 | -- | -- | 13793% 0.29K to 40.29K | |
| 24-Jan-23 9:07 PM View: | Levin Arthur A Chief Scientific Officer | Avidity Biosciences, Inc. (RNA) | 20-Jan-23 | Grant | 18,000 | -- | -- | 7% 275.2K to 293.2K | |
| 24-Jan-23 9:04 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 20-Jan-23 | Grant | 20,000 | -- | -- | 2088% 0.96K to 20.96K | |
| 17-Jan-23 8:50 PM View: | Levin Arthur A Chief Scientific Officer | Avidity Biosciences, Inc. (RNA) | 12-Jan-23 | Option Exercise | 10,000 | $1.24 | $12,400.00 | 4% 275.2K to 285.2K | |
| 17-Jan-23 8:50 PM View: | Levin Arthur A Chief Scientific Officer | Avidity Biosciences, Inc. (RNA) | 12-Jan-23 | Planned Option Sale | 10,000 | $22.00 | $220,028.00 | (4%) 285.2K to 275.2K |
